Research map: Response to correspondence on “How long do people with rheumatic and musculoskeletal diseases stay healthy and in work across Europe?”

Back to the article

Papers in this map

  1. Population-based estimates of healthy working life expectancy in England at age 50 years: analysis of data from the English Longitudinal Study of Ageing · Marty Parker · 2020 · 105 citations · Cited by this paper
  2. Thresholds for efficacy outcomes in psoriatic arthritis vary according to baseline disease activity but not according to prior tumour necrosis factor inhibitor treatment · 2026 · Related
  3. Anticipated significant work limitation in primary care consulters with osteoarthritis: a prospective cohort study · Ross Wilkie · 2014 · 26 citations · Cited by this paper
  4. Response to correspondence on ‘Final validation of the hierarchical framework for outcomes in axial spondyloarthritis: longitudinal determinants of health-related quality of life’ · 2026 · Related
  5. Gender, education, and cohort differences in healthy working life expectancy at age 50 years in Australia: a longitudinal analysis · Mitiku Teshome Hambisa · 2023 · 15 citations · Cited by this paper
  6. Mitochondrial-impaired ductal epithelium fuels TLS formation in Sjögren’s disease · 2026 · Related
  7. Educational and gender disparities in healthy working life expectancy among middle-aged and older adults in South Korea · Munyoung Yang · 2025 · 3 citations · Cited by this paper
  8. Development and validation of quality indicators for lupus nephritis, based on the 2025 EULAR recommendations: adherence trends and impact on clinical outcomes · 2026 · Related
  9. How long do people with rheumatic and musculoskeletal diseases stay healthy and in work across Europe? Analysis of data from SHARE and ELSA · Ross Wilkie · 2026 · 1 citation · Cited by this paper
  10. Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis · 2026 · Related
  11. Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries · 2026 · Related
  12. Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma · 2026 · Related
  13. Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project · 2026 · Related

Source: OpenAlex (CC0)